REDTALKS : OUR SERIE OF SCIENTIFIC WEBINARS
CALYM Institute is pleased to announce the launch of scientific webinars on research subjects linked to lymphoma.
You are invited to discover, participate and be part of the lymphoma research community.
-
On the 1st Thursday of each month
-
For one hour, starting 6pm CET
-
For free and for everyone
- In English

SEASON 4: WATCH REPLAYS

REDTALKS S4#2: IDH2 MUTATION IN T-CELL LYMPHOMA: NEW MOUSE MODEL TO INVESTIGATE IDH2 MUTATION IMPACT

REDTALKS S4#1: NOVEL INSIGHT INTO THE PATHOGENESIS OF MEDIASTINAL LYMPHOMAS

COMING SOON!
SEASON 3: WATCH REPLAYS

REDTALKS S3#7: MYC-TRANSLOCATED LEUKEMIAS AND LYMPHOMAS: FROM MULTI-OMICS ANALYSES TO PATHOGENETIC CONCEPTS

See you next season!

See you next season!

REDTALKS S3#6: METABOLIC REGULATION OF HEMOPOIETIC MALIGNANCY

REDTALKS S3#5: COMBINING GLOFITAMAB WITH COSTIMULATORY BISPECIFICS

REDTALKS #4 SAISON 3: PATHOGENESIS OF HODGKIN LYMPHOMA

REDTALKS #3 SAISON 3: UNDERSTANDING THE ROLE OF ONCOGENIC DRIVERS IN T-CELL LYMPHOMA

REDTALKS #2 SAISON 3: TARGETING THE COMMON PROGENITOR CELL TO CURE FOLLICULAR LYMPHOMA

REDTALKS #1 SAISON 3: THE SINGLE-CELL PATHOLOGY LANDSCAPE OF DIFFUSE LARGE B CELL LYMPHOMA
SEASON 2: WATCH REPLAYS

REDTALKS S2#6: APPLICATION OF PET SCANNING IN B CELL LYMPHOMA

REDTALKS SEASON2#5: CAR-T CELLS: NEW TARGETS AND POTENTIAL STRATEGIES FOR CANCER PATIENTS

REDTALKS SEASON2#4: COULD POLATUZUMAB DETHRONE USUAL REGIMEN FOR DLBCL PATIENTS?

REDTALKS SEASON2 #3: CIRCULATING TUMOR DNA (CTDNA) AND LYMPHOMA

REDTALKS SEASON2 #2: PDX A POWERFUL TOOL OF NEW DISCOVERIES AND IMPROVED TREATMENTS

REPLAY: REDTALKS SEASON2 #1: A MACRO VIEW OF THE TUMORAL MICROENVIRONMENT
SEASON 1: WATCH REPLAYS

REDTALKS #1 LYMPHOMA SUGARCOATED

REDTALKS#2 : WHY AI HYPE SHOULD NOT MAKE US LOSE COMMON SENSE?

REDTALKS#3 : “GENETICS PROPOSES, EPIGENETICS DISPOSES”. BUT IT’S ALL IN THE GENES…

REDTALKS #4 DRIVING TOWARD PRECISION MEDICINE FOR MANTLE CELL LYMPHOMA

REDTALKS #5: CD19 CAR T CELLS FOR B-CELL NHL AND CLL: LESSONS LEARNT AND NEXT STEPS

REDTALKS #6: UNDERSTANDING T-CELL LYMPHOMA

REDTALKS #7 : FROM 2 CANCER CENTERS TO INDUSTRY: DRIVING PROGRESS IN BLOOD CANCERS

REDTALKS #8 DEDICATED TO OUR MEMBERS

REDTALKS #9 : EPIGENETIC BASES AND THERAPY LYMPHOMA